絞り込み

16548

広告

Association of Polypharmacy With Mild Cognitive Impairment and Cognitive Ability: A Nationwide Survey in Taiwan.

著者 Cheng CM , Chang WH , Chiu YC , Sun Y , Lee HJ , Tang LY , Wang PN , Chiu MJ , Yang CH , Tsai SJ , Tsai CF
J Clin Psychiatry.2018 Sep 25 ; 79(6):.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (17view , 0users)

Full Text Sources

Polypharmacy, defined as the concomitant use of 5 or more medications, has a documented negative association with cognitive impairment such as delirium and is associated, potentially, with a higher risk of dementia. However, whether polypharmacy contributes to increased risk of mild cognitive impairment (MCI) or decreased cognitive capacity requires further investigation. This nationwide population survey investigated the association among polypharmacy, MCI, and dementia.
PMID: 30256550 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード